Sarah A. Holstein, MD, PhD, on Multiple Myeloma: New Induction Therapies

Posted: Wednesday, August 1, 2018

Sarah A. Holstein, MD, PhD, of the University of Nebraska Medical Center, discusses the current standard of treatment for multiple myeloma, the benefit of upfront transplant, and ongoing studies that will better define the value of adding monoclonal antibody therapy.